Nitric Oxide Synthase and Oxidative Stress: Regulation of Nitric Oxide Synthase by Ehab M. M. Ali et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
4 
Nitric Oxide Synthase and Oxidative Stress: 
Regulation of Nitric Oxide Synthase 
 Ehab M. M. Ali1, Soha M. Hamdy2 and Tarek M. Mohamed1 
1Biochemistry Division, Chemistry Department, 
 Faculty of Science, Tanta University. Tanta, 
 2Biochemistry Division, Chemistry Department,  
Faculty of Science, Fayoum University, Fayoum, 
Egypt 
1. Introduction 
Nitric oxide has been found to play an important role as a signal molecule in many parts of 
the organism as well as a cytotocic effector molecule of nonspecific immune response. Nitric 
oxide is very important functions both in helminthes and mammalian hosts. Nitric oxide 
may react with proteins and nucleic acids. In addition to binding to heme groups, e.g. of 
guanylate cyclase, hemoglobin, and cytochrome C oxidase, NO may react with nucleophilic 
centers like sulfur, nitrogen, oxygen and aromatic carbons. The prime target for covalent 
binding of NO to a functional groups in proteins under physiological condition in the 
presence of oxygen are SH groups. The intra-mitochondrial reaction of NO with superoxide 
anion yields peroxynitrite, which irreversibly modifies susceptible targets within the 
mitochondria, inducing oxidative and/or nitrative stresses. The signal molecule of NO is 
synthesized by constitutive nitric oxide synthase (cNOS). The killer molecule NO is 
synthesized by inducible NOS (iNOS). There is no signal or killer NO – it depends on the 
environments and partners involved – be very careful in that. Yes, the production is 
regulated in different ways. Inducible NOS is induced by numerous inflammatory stimuli, 
including endotoxin, cytokines and excretory/secretory products (ESP) of helminthes. ESP 
directly interact with the immune system and modulate host immunity. Nitric oxide is a 
highly reactive and unstable free radical gas that is produced by oxidation of L- arginine by 
oxygen and NADPH as electron donor to citrulline mediated by a family of homodimer 
named nitric oxide synthase. In addition to L- arginine-NO pathway, L-arginine is also 
metabolized to L-ornithine and urea by arginase enzyme. A side from blocking NO 
synthesis by depleting the cell of substrate for NOS, the arginase-mediated removal of L-
arginine inhibits the expression of inducible NOS (iNOS) by repressing the translation as 
well as the stability of iNOS protein. Furthermore, arginase may inhibit iNOS-mediated NO 
production through the generation of urea. 
2. Chemistry of nitric oxide 
Nitrogen monoxide, called nitric oxide (NO) is an endogenous short lived free radical that 
freely diffuses within cells from formation to action site. Nitric oxide exhibits an enormous 
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range of important functions in the organism. Nitric oxide interacts with other biomolecules 
and can combine with superoxide anion (another free radical) to form an unstable 
intermediate peroxynitrite which may initiate tissue injury. Peroxynitrite may also decompose 
to form a strong oxidant hydroxyl radical. Nitric oxide, peroxynitrite and hydroxyl radical are 
capable of oxidizing lipids, proteins, and nucleic acids. Nitric oxide is also a major signaling 
molecule in neurons and immune system, either acting on the cell in which it is produced or 
by penetrating cell membranes to affect adjacent cells (Zhang and Li, 2006). 
Nitric oxide has been shown to be a mediator of cell injury in some pathological conditions. 
NO has toxic effects at high concentrations, it reacts with oxygen and superoxide. The 
product of the reaction with superoxide is peroxynitrite (ONOO-), also it is which 
decompose to form .OH radical. Reaction of nitric oxide and H2O2 yields singlet oxygen 
(1O2). Also, the reaction pathway of NO with molecular oxygen yields nitrogen diioxide 
(NO2) and dinitrogen trioxide (N2O3). 
NO. + O2 → ΟΝΟΟ−, ΝΟ2., Ν 2Ο3 
ΝΟ.  + Ο2−. →  ΟΝΟΟ− 
ΝΟ. + Η2Ο2 → 1O2 
Nitric oxide secreted by activated cells to be a complex "cocktail" of substances. The effect of 
these reactive species is particularly relevant to cell injury (Rosen et al., 2002). 
3. Nitric oxide synthases: Structure and function 
Nitric oxide is a highly reactive and unstable free radical gas that is produced by oxidation of 
L-arginine by oxygen and NADPH as electron donor to citrulline mediated by a family of 
homodimmer named nitric oxide synthase. In addition to L-arginine-NO pathway, L-arginine 
is also metabolized to L-ornithine and urea by arginase enzyme (Durante et al., 2007). 
The nitric oxide synthase isoforms include the neuronal type I, (nNOS), the inducible form 
type II (iNOS) and endothelial type III (eNOS), whereas the nNOS and eNOS are 
constitutively expressed enzymes (cNOS). Constitutive nitric oxide synthase produces NO 
for short period of time (seconds to minutes). Inducible nitric oxide synthase expression is 
induced by inflammatory cytokines and toxins leads to the production of much higher 
amounts of NO compared to the cNOS, once iNOS expressed produces NO for long period 
of time (hours to days). Inducible NOS typically synthesizes 100-1000 times more than 
constitutive nitric oxide synthase. The major differences between cNOS and iNOS activities 
do not reside in the concentrations of NO generated per enzyme, but rather in the duration 
of NO produced. In addition, iNOS protein content in fully activated cells may be higher 
than cNOS content. Thus, cytotoxicity usually correlates with the product of iNOS and not 
with the product of the two cNOS. Thus the regulated pulses versus constant unregulated 
NO synthesis differentiates between messenger and the killer properties of NOS (Rabelink 
and Luscher, 2006). 
The constitutive form of NOS is anchored on the internal surface of the endothelial cell 
membranes continuously present, although not always active. Its activity by the endothelial 
cells and neurons is responsible for maintenance of physiological homeostasis such as blood 
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pressure and blood flow, controlling leukocyte - endothelial interactions and signaling 
among neurons. The constitutive isoform was distinguished from the inducible form based 
on the dependence of the constitutive enzyme activity on calmodulin (Wendy et al., 2001). 
Other cofactors required for all enzyme forms are flavin mononucleotide, flavin adenine 
dinucleotide, heme and tetrahydrobiopterin. The constitutive enzyme requires calcium ion 
(Ca2+) for activity while the inducible enzyme dose not (Wendy et al., 2001). 
The inducible NOS form represents a newly synthesized enzyme, which is expressed in 
response to specific stimuli, such as endotoxin and cytokines leading to enhanced NO 
production for many hours without further stimulation. It is expressed in multiple cell 
types, including macrophages, vascular smooth muscle cells, vascular endothelial cells and 
hepatocytes. The expression of iNOS may be beneficial in host defense or in modulating the 
immune response; indeed, the massive NO production by iNOS from macrophages during 
infections inhibits the growth of many pathogens (Wendy et al., 2001; Madar et al., 2005). 
Nitric oxide synthase protein is a dimer formed of two identical subunits. There are three 
distinct domains in each NOS subunit: a reductase domain, a calmodulin-binding domain 
and an oxygenase domain (Li and Poulos, 2005). 
1. The reductase domain: This domain contains the flavin adenine dinucleotide (FAD) 
and flavin mononucleotide (FMN) moieties and acts to transfer electrons from NADPH 
to the oxygenase domain of the opposite subunit of the dimer, and not to the domain of 
the same subunit. 
2. Calmodulin-binding domain: The binding of calmodulin is required for the activity of 
all the NOS isoforms. It connects NO and calcium homeostasis. 
3. The oxygenase domain: This domain contains the binding sites for tetrahydrobiopterin, 
heme and arginine. The oxygenase domain catalyzes the conversion of arginine into 
citrulline and NO. 
Several factors affect the synthesis and catalytic activity of iNOS particularly, dimerization of 
NOS monomers. NOS isoforms are only active as homodimers. The dimerization of NOS 
monomers is promoted by heme, resulting in rapid conformational changes that, by 
cooperative action of tetrahydrobiopetrin (BH4) and L-arginine, leads to a stable and active 
enzyme. Moreover, an intracellular depletion of heme, BH4 and/or L-arginine considerably 
contributes to decreased resistance of NOS enzymes to proteolysis (Dunbar et al., 2004). 
4. Molecular nitric oxide targets in cells 
The broad spectrum of effects performed by NO can be exerted through two main 
mechanisms: the activation of guanylate cyclase (which can be soluble in the cytosol or 
coupled to the cell membrane) or through its interaction with the major cellular source of 
superoxide anion, the NO/cytochrome C oxidase, which is found in mitochondria (Gha-
fourifar and Cadenas 2005; Poulos 2006). 
The guanylate cyclase-dependent effects of NO mainly affect the vascular tonus thereby 
affecting the inflammatory reaction by increasing synthesis of guanosine 3’,5’-
monophosphate (cGMP), it acts as inhibitors of platelets aggregation. Other effects 
pertaining to mitochondrial functions involve the respiratory burst. Mitochondria can 
produce NO through its own Ca2+-sensitive synthase (mitochondrial, mtNOS). This enzyme 
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regulates mitochondrial oxygen consumption and transmembrane potential via a reversible 
reaction with cytochrome C oxidase. The intramitochondrial reaction of NO with superoxide 
anion yields peroxynitrite, which irreversibly modifies susceptible targets within the 
mitochondria, inducing oxidative and/or nitrative stress (Ghafourifar and Cadenas 2005). 
In addition to their primary role in the production of energy (ATP), mitochondria generate 
reactive oxygen species (ROS) that can directly or indirectly affect the NO response. Since 
NO and ONOO- can inhibit cellular respiration at the level of cytochrome C oxidase and 
complexes I-III, respectively, it has been suggested that mitochondrial function can influence 
the balance between apoptosis and necrosis induced by NO. Nitric oxide can stimulate the 
biogenesis of mitochondria in a guanosine 3’,5’-monophosphate (cGMP)-dependent manner 
(Nisoli et al. 2003; Poderoso 2009). 
Nitric oxide may react with proteins and nucleic acids. In addition to binding to heme 
groups, e.g. of guanylate cyclase, hemoglobin, and cytochrome C oxidase, NO may react 
with nucleophilic center like sulfur, nitrogen, oxygen and aromatic carbons. The prime 
target for covalent binding of NO to a functional groups in proteins under physiological 
condition in the presence of oxygen is the SH group. NO has been shown to N-nitrosylate 
primary arylamine of nucleotides and subsequent hydrolysis yield deamianted nucleotide. 
NO also mediates Fe+2 release from target cells, destroying Fe-S clusters in enzymes, like the 
citric acid cycle enzyme aconitase or ferrocheletase, which catalyse Fe+2 into protoporphyrin. 
NO can inhibit several interacellular enzymes and profoundly affect the cellular gene 
transcription machinery (Laurent  et al., 1996; Alderton et al., 2001). 
The high toxicity of inducible NO comes from its high concentration and from its reactivity 
with oxygen and oxygen-related reactive intermediates, which yield numerous toxic species 
that have enzymatic and DNA-damaging properties (Alderton et al., 2001). 
Depletion of glutathione, inhibition of mitochondrial superoxide dismutase (SOD), and 
perhaps the loss of other antioxidant defense mechanisms could permit a rise in the 
endogenous level of reactive oxygen species normally produced by metabolism, which is 
likely to enhance the toxicity of NO. By this route, reactive nitrogen and oxygen species may 
act in concert to inactivate the key metabolic enzymes and cause lipid peroxidation and 
DNA strand breaks that result in irreversible cell injury and death (Radi, 2004; (Hummel et 
al., 2006). 
5. Protective and cytotoxic function of nitric oxide 
In the cardiovascular system, nitric oxide plays a major role in the regulation of blood flow 
and blood pressure as well as the general homeostatic control of the vasculature. Nitric 
oxide also inhibits platelet aggregation and adhesion by a mechanism dependent on cyclic 
GMP. It may also be involved in the interaction of leucocytes with vessel walls, since it 
inhibits leukocytes activation (Bian et al., 2008). 
NO reacts with iron in the active side of the enzyme guanylate cyclase (GC), stimulating it 
to produce the intracellular mediator cyclic (cGMP), that in turn enhances the release of 
neurotransmitters resulting in smooth muscle relaxation and vasodilation (Esplugues, 
2002). 
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In the central nervous system, accumulating evidence indicates that nitric oxide plays a part 
in the formation of memory. It is also found in some peripheral nerves, where it may 
contribute to sensory transmission (Sunico et al., 2005; Zochodne and Levy, 2005). 
The effects of NO can be direct or indirect and can influence several physiological processes, 
ranging from DNA transcription and replication to protein synthesis and secretion. Under 
physiological conditions, NO mediates homeostatic anti-inflammatory reactions, such as 
inhibition of neutrophil adhesion, cyclooxygenase activity, cytokine production, osteoclast 
bone resorption, among others, in order to prevent autoimmunity (Dal -Secco et al., 2006; 
Fukada et al., 2008; Livonesi et al., 2009). 
Generation of NO by endothelial cells causes smooth muscle relaxation through activation 
of guanylate cyclase by nitrosation of its heme group. It is hypothesised that NO may have 
originated in host as a mechanism of first-line defense against intracellular pathogens. This 
theory has been confirmed by the wide occurrence of the enzyme responsible for NO 
production, NO-synthase, in several species, ranging from invertebrates to mammals and 
non-mammalian vertebrates (Ribeiro et al., 1993; Fukada et al., 2008). 
In mammals, NO production is upregulated in response to infection by a wide range of 
unicellular organisms such as bacteria, yeast and parasites (Cardoni et al., 1990). Evidently, 
evolutionary diversity has induced NO synthesis to be performed in response to different 
kinds of stress stimuli. In fact, several antigens derived from intracellular parasites can be 
recognized by innate immune receptors on macrophages, triggering NOS activity 
(MacMicking et al., 1997; Livonesi et al., 2009). 
Nitric oxide plays a significant role in acute and chronic inflammation i.e. excessive production 
of NO contributes to vasodilation and tissue damage which characterize many inflammatory 
conditions. Also, NO appears to play an important role in the functions of immune system as a 
cytotoxic macrophage effector molecule, modulator of polymorphonuclear leucocytes 
chemotaxis and adhesion, mediator of tissue injury caused by adhesion of immune complexes, 
and a regulator of lymphocyte proliferation (Shah et al., 2004). 
Cytokines and NO can modulate the production of chemokines and adhesion molecules in 
vivo and in vitro, influencing the course of infection (Savino et al., 2007; Machado et al., 
2008). Chemokine receptors are also involved in cellular activation during parasitic 
infections and this G-protein-coupled signalling pathway is implicated in NO production as 
well (Benevides et al., 2008). 
NO is perhaps the most important among the group of early mediators produced by cells of 
the innate immune system. Phagocytes constitute the first line of microbial defense and they 
function by sensing the presence of different types of infectious agents (Carneiro-Sampaio 
and Coutinho, 2007) through pattern recognition receptors, including Toll-like receptors 
(TLRs) and the most recently described NOD- (NLRs) receptors. These receptors recognize 
multiple microbial patterns; therefore, they are critical for triggering the production of 
inflammatory mediators and essential for activation of the adaptive immune response 
(Schnare et al., 2001; Kanneganti et al., 2007; Underhill, 2007). 
Nitric oxide synthase is produced by antigen-presenting cells (APC) during antigen 
processing and presentation to T cells and it can modulate various functions of APCs. It can 
inhibit the expression of major histocompatibility complex class II molecules in activated 
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macrophages and, at high concentrations, may also inhibit IL-12 synthesis, thus contributing 
to the desensitization of macrophages after exposure to inflammatory stimuli (Salvucci et al., 
1998; Pahan et al., 2001; van der Veen, 2001). In chronic immune responses to intracellular 
pathogens, NO is reported to play a regulatory role and may promote parasite persistence. 
For these reasons, it is suggested that NO is cytostatic rather than cytotoxic for parasites 
(Jana et al., 2009). 
NOS enzymes or NO-activity-derived products (nitrites or nitrotyrosine) have been detected 
in different locations of adult worms. Neural NOS and iNOS have been found in the nervous 
tissue and in the parenchyma of Schistosoma mansoni respectively (Kohn et al., 2001). The 
presence of NOS has been also demonstrated in Ascaris suum; Toxocara canis; F. gigentica (Fan et 
al., 2004; Hamdi and Ali, 2009). Nitric oxide synthase is located in the muscular wall from 
adult worms in Brugia malayi, Dirofilaria immitis and Acanthocheilonema vitae filariae (Pfarr et al., 
2001). Expression of endothelial NOS (eNOS) has been detected in the cuticle and stichocytes 
from Trichinella britovi (Masetti et al., 2004). Nitrites have been detected in the hydatid liquid of 
fertile Echinococcus granulosus. Expression of iNOS and nNOS has been detected in the 
parenchyma and nervous structures of the filariform larvae from Strongyloides venezuelenesis. 
Moreover, NOS expression has also been demonstrated in other phases, such as eggs, 
sporocysts, and cercariae of Schistosoma sp. (Long et al., 2004) and other structures as oocytes, 
spermatozoids, and embryonic forms of Brugia malayi (Pfarr et al., man 2001). 
A dual role in the immunity is usually observed for NO. This well-known immune duality is 
usually dependent on concentration and, once dysregulated, may lead to host cell toxicity, 
autoimmunity or parasite persistence due to immune evasion, all of which can lead to 
pathology. The strength of NO toxicity is dependent on the sensitivity of the parasite, which 
differs among parasite strains and according to the physiological microenvironment 
(Gutierrez et al., 2009). 
Specifically, both adult worms’ excretory/secretory antigens and larval somatic antigens of 
T. canis are capable of stimulating in vitro the production of NO at transcriptional level in rat 
alveolar macrophages. The stimulation of NO production by antigens of T. canis LII 
(extracted from excretory/secretory product) does not seem to play a host-defensive role. 
The production of NO by host cells, activated by the parasite, has negative effects not on 
parasite survival but on the host, and thus putatively represents a parasite evasion 
mechanism. Types of parasite evasion/adaptation mechanisms largely depend on the 
parasite’s migration and definitive anatomical location. T. canis is characterized by its 
dissemination (migration) through the bloodstream until it reaches its final inside the host. 
This bloodstream migration would be clearly facilitated by blood-vessel dilatation described 
toxocariasis models. Deleterious effects were attributed on the host physiology in the release 
of NO by host cells, induced by the parasite itself (Espinoza et al., 2002). Thus, production of 
NO during migration of T. canis LII inside their host could facilitate their migration and 
triggering of this production by LII may represent a parasite adaptation mechanism (Muro 
and Perez-Arellano, 2010). 
The effect of different antigens of excretory/secretory of larval and adult worms of 
nematodes, on NO production from rat alveolar macrophages was observed. 
Excretory/secretory antigens from adult worms in Toxocara canis and Strongyloides 
venezuelensis stimulated the NO production from alveolar macrophages (Espinoza et al., 
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2002). The cytoplasmatic signalling pathways involved in the NO production after 
stimulation with adult excretory/secretory antigen of Toxocara canis. It was suggested that 
phospholipase C macrophage pathways play an essential role in activating the production 
of NO triggered by this antigen. This suggests that NO production could be due to an 
increase of intracellular calcium and activation of the arachidonic acid pathway. Moreover, 
Toxocara canis excretory/secretory adult antigen also stimulated alveolar macrophages to 
produce prostaglandin E2 (PGE2). These results indicate that Toxocara canis can stimulate the 
release of vasodilatory mediators by host macrophages (Espinoza et al., 2002; Hewitson et.al, 
2009; Muro and Perez-Arellano, 2010). 
6. Regulation of nitric oxide synthase 
Inhibition of arginase has been shown to stimulate NO synthesis in endothelial cells. In 
addition, overexpression of arginase І or arginase П supresses NO generation in endothelial 
cells and this is associated with a significant decrease in intracellular L- arginine content (Li 
et al., 2001). Interestingly, constitutive expression of arginase in microvascular endothelial 
cells counteracts NO-mediated dilation, suggesting that arginase subserves a tonic 
vasoconstrictor function (Chicoine et al., 2004; Johnson et al., 2005). 
A side from blocking NO synthesis by depleting the cell of substrate for NOS, the arginase-
mediated removal of L- arginine inhibits the expression of inducible NOS (iNOS) by 
repressing the translation as well as the stability of iNOS protein. Furthermore, arginase 
may inhibit iNOS-mediated NO production through the generation of urea. These findings 
suggest that arginase downregulates NO formation via multiple mechanisms. Interestingly, 
N-hydroxy-L-arginine, an intermediate formed during the catalysis of L-arginine by NOS, is 
a potent inhibitor of arginase, suggesting that NOS may also influence arginase activity 
(Johnson et al., 2005). 
Thus, arginase has recently been emerged as a critical regulator of NO synthesis that may 
contribute to the development of numerous pathologies, including vascular disease. The 
release of NO by endothelial NOS (eNOS) plays a crucial role in preserving vascular 
homeostasis. In response to changes in shear stress or receptor stimulation, NO is released 
from the vascular endothelium to promote blood flow by inhibiting vascular tone and 
platelet aggregation (Durante, 2007). 
Aminoguanidine has effects on several enzyme systems. It interferes with non-enzymatic 
glycosylation. Aminoguanidine inhibits nitric oxide synthase (NOS), particularly its 
inducible form (iNOS), reducing the pathological effects due to over-activity of these 
enzymes and thus to over-production of NO. Aminoguanidine may affect of polyamine 
metabolism (Kolodziej et al., 2006). 
NO synthesis inhibitors have been used in vivo to evaluate their effect on parasitic infection. 
This strategy has mainly been used in experimental models of filariosis by Brugia malayi, 
toxocariosis, trichinellosis, and strongyloidiasis. The results obtained are divergent, since the 
use of aminoguanidin diminishes the lesions in toxocariosis, whereas it increases the 
parasite load in filariosis and strongyloidiasis. Moreover, mice treated with 
aminoguanidine, at the beginning of muscle phase of the infection, inhibit the reduction of 
muscle larvae number and cells of inflammatory infiltrates did not show any specific iNOS 
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reaction]. Influence of the inhibition of the NO production by iNOS in a toxocariosis 
experimental model decreases the deleterious effects of the parasite upon the host, 
especially the lung vascular alterations (Muro and Perez-Arellano, 2010). 
Oxalomalate, a tricarboxylic acid structurally related to citrate, has long been known to be a 
powerful competitive inhibitor of both aconitase, which is required for the first step of citric 
acid cycle, and NADP dependent isocitrate dehydrogenase. NO modulates also the activity 
of several other proteins including mitochondrial aconitase, an iron-dependent enzyme and 
isocitrate dehydrogenase (Irace et al., 2007). 
OMA inhibits aconitase and isocitrate dehydrogenase, the Krebs cycle flux appears to be 
constricted at two steps with a consequent reduction of its biosynthetic ability caused by the 
limited availability of the successive intermediates, namely α-ketoglutarate, a precursor of 
L-arginine, and succinyl-CoA, a precursor of heme. In fact, exogenous treatment with α-
ketoglutarate or succinyl-CoA partially or almost completely restored NO production which 
was inhibited by OMA. As heme is the sole cofactor absolutely required for the formation of 
active NOS dimers and the binding of L-arginine to iNOS facilitates its dimerization, the 
partial slowdown of Krebs cycle induced by OMA, leading a consequent decrease of 
succinyl-CoA and α-ketoglutarate formation, could explain the effect of OMA on NO 
production. Moreover, inhibition by OMA of the NADP+-dependent isocitrate 
dehydrogenase reduces the availability of NADPH, a source of electrons in the NOS 
enzymatic reaction.This impairment, together to the depletion of L-arginine caused by α-
ketoglutarate shortage, may prevent NO biosynthesis(Irace et al., 2007). 
It is known that NOS are long-lived proteins and the presence of heme and L-arginine or 
BH4 considerably contributes to their resistance to proteolysis. Consequently, the coupled 
shortage of heme and L-arginine caused by OMA may determine instability of NOS dimers, 
and consequently, lower resistance to proteolysis. This hypothesis is supported by the 
observed reduction of iNOS protein content both in LPS-stimulated macrophage treated 
with OMA and in peritoneal macrophages recovered from LPS-stimulated rats after 
injection of OMA precursors (Osawa et al., 2003). 
7. Conclusion 
It is well known that, glutathione interacts with reactive species derived from NO oxidation 
and converts these species to less toxic ones Therefore, depletion of glutathione, inhibition 
of mitochondrial superoxide dismutase (SOD), and perhaps the loss of other antioxidant 
defense mechanisms could permit a rise in the endogenous level of reactive oxygen species 
normally produced by metabolism, which is likely to enhance the toxicity of NO 
development of NOS inhibitors constitutes a current strategy in the research of new 
compounds showing interesting properties. Inhibition of NO production would be 
beneficial for the host 
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